0
Correction
Erratum
Psychiatric News
Volume 37 Number 14 page 25-25

In the the article "New Antipsychotic Boasts Better Side-Effect Profile" in the June 21 issue, the discovery and development of a new antipsychotic drug, aripiprazole, were attributed solely to Bristol-Myers Squibb Company (BMS). Aripiprazole was originally discovered by Otsuka Pharmaceutical Company Ltd. of Japan. Otsuka and BMS then codeveloped the drug and will promote the medication under the proposed brand name Abilitat, for the treatment of schizophrenia, pending FDA approval. ▪

Interactive Graphics

Video

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Articles
Articles